FDA approves new nasal spray to treat potentially life-threatening allergic reactions – CBS News
On Friday, the FDA approved Neffy, the first nasal spray to be used as an emergency treatment for tens of millions of Americans at risk of potentially life-threatening allergic reactions. CBS News medical contributor Dr. Celine Gounder explains what to know about the new needle-free alternative to the EpiPen.
Be the first to know
Receive browser notifications for breaking news, live events and exclusive reporting.